The Nonclinical and Translational Development/Early Phase Clinical Development Track will showcase discovery to development topics in the nonclinical, preclinical, and biotechnology arenas.

At the conclusion of this meeting, participants should be able to:
• Explain some of the latest nonclinical and clinical technologies and approaches for assessing the safety of pharmaceutical products
• Discuss recent advances in coping with particularly challenging regulatory and scientific issues that arise in the early phases of novel pharmaceutical development
• List current strategies for designing successful early clinical pharmacology and experimental medicine trials

**Please note workshops that were made available during the Annual Meeting included attendee interactivity. Due to such format, audio recordings may not be available.